TVTX FY 2017 Earnings — Travere Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TVTXTravere Therapeutics, Inc.

$3B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$155M+16.0% YoY

Gross Profit

$151M97.7% margin

Operating Income

-$54M-34.7% margin

Net Income

-$60M-38.6% margin

EPS (Diluted)

$-1.54

Cash Flow

Operating Cash Flow

$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$27M

Balance Sheet

Total Assets

$520M

Total Liabilities

$227M

Stockholders' Equity

$293M

Cash & Equivalents

$99M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$155M	$134M	+16.0%
Gross Profit	$151M	$129M	+17.3%
Operating Income	-$54M	-$58M	+7.6%
Net Income	-$60M	-$48M	-24.7%